Bengaluru: German biotechnology company BioNTech has reached two separate settlement agreements with the U.S. National ...

The German pharmaceutical company BioNTech announced on Friday that it has reached settlements in the US to resolve a ...

BioNTech SE ( (BNTX) ) has provided an update. BioNTech SE has settled a dispute with the National Institutes of Health (NIH) regarding royalties allegedly owed on sales of its COVID-19 vaccine, ...

BioNTech SE has reached a settlement agreement with the University of Pennsylvania over a royalty dispute related to its COVID-19 vaccine, developed in collaboration with Pfizer. The agreement ...

BioNTech SE ADR closed $17.54 below its 52-week high ($131.49), which the company achieved on September 17th.

The German pharmaceutical company BioNTech announced on Friday that it has reached settlements in the US to resolve a ...

Concurrently, the company has amended its license agreements to provide for a low single-digit percentage royalty on Net Sales of Licensed Products for 2024 onwards. Currently, BioNTech's stock is ...

game se paise kaise kamaye Pfizer/BioNTech COVID-19 vaccine first granted emergency use authorization in the UK The Lancet reveals the secrets of anti-cancer missile ADC drugs: 5 marketed products and ...

BioNTech (BNTX) stock slipped after signing $1B deals with NIH and the University of Pennsylvania to resolve COVID vaccine ...

The ADR's fall snapped a three-day winning streak.

There is plenty to like about Merck ( MRK -0.17%). It is one of the largest pharmaceutical companies and the owner of the ...